Menu

Guardant Health, Inc. GH

Full chart Compare
Set alert

Price alert · GH

All alert types
153.43 USD -15.15 (-8.99%)

At closeNov 6, 2026, 7:52 AM EST

143.00 -10.43 -6.80%

Pre-market · Nov 6, 7:52 AM ET

151.92 Day range 165.10
74.55 52-week range 191.05
YTD
+50.22%
1 year
+59.41%

Revenue & Expenses

Revenue by
Other Income → Expenses: $19.71MOncology → Revenue: $683.60MIncome Tax Benefit → Expenses: $1.26MExpenses → Selling, General & Admin: $706.07MExpenses → Research & Development: $364.19MGross Profit → Expenses: $633.01MRevenue → Gross Profit: $633.01MRevenue → Cost of Revenue: $349.01MBiopharma & Data → Revenue: $210.13MNet Loss → Expenses: $416.28MScreening → Revenue: $79.73MLicensing & Other → Revenue: $8.56MOther Income$19.71MIncome Tax Benefit$1.26MGross Profit$633.01MNet Loss$416.28MCost of Revenue$349.01MExpenses$1.07BSelling, General & Admin$706.07MResearch & Development$364.19MRevenue$982.02MOncology$683.60MBiopharma & Data$210.13MScreening$79.73MLicensing & Other$8.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

GH annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
982.02M739.02M563.95M449.54M373.65M
633.01M449.22M336.90M293.21M250.74M
-437.25M-443.59M-564.73M-544.38M-411.00M
-416.28M-436.37M-479.45M-654.59M-405.67M
-3.32-3.56-4.28-6.41-4.00
GH annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
489.42M629.75M1.13B141.65M492.20M
2.01B1.49B1.79B1.61B2.20B
2.11B1.63B1.63B1.55B1.56B
1.68B1.31B1.33B1.35B1.36B
-99.31M-139.65M158.68M60.18M645.00M
GH annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-184.76M-239.86M-324.98M-309.46M-209.02M
-627.20M-261.31M840.25M149.82M-63.16M
671.13M-996.00K477.38M-189.09M-66.82M
-48.31M-35.09M-20.49M-77.46M-75.03M
-140.34M-503.93M991.74M-350.34M-340.69M